Works matching DE "CANCER radioimmunotherapy"

Results: 32
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Abstracts.

    Published in:
    1995
    Publication type:
    Abstract
    22
    23

    Cancer radioimmunotherapy with alpha-emitting nuclides.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 5, p. 601, doi. 10.1007/s00259-005-1803-2
    By:
    • Couturier, Olivier;
    • Supiot, Stéphane;
    • Degraef-Mougin, Marie;
    • Faivre-Chauvet, Alain;
    • Carlier, Thomas;
    • Chatal, Jean-François;
    • Davodeau, François;
    • Cherel, Michel
    Publication type:
    Article
    24

    <sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.

    Published in:
    British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
    By:
    • Samaniego, Felipe;
    • Berkova, Zuzana;
    • Romaguera, Jorge E.;
    • Fowler, Nathan;
    • Fanale, Michelle A.;
    • Pro, Barbara;
    • Shah, Jatin J.;
    • McLaughlin, Peter;
    • Sehgal, Lalit;
    • Selvaraj, Vijairam;
    • Braun, Frank K.;
    • Mathur, Rohit;
    • Feng, Lei;
    • Neelapu, Sattva S.;
    • Kwak, Larry W.
    Publication type:
    Article
    25
    26
    27

    Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases.

    Published in:
    JAMA: Journal of the American Medical Association, 2006, v. 295, n. 21, p. 2483, doi. 10.1001/jama.295.21.2483
    By:
    • Aoyama, Hidefumi;
    • Shirato, Hiroki;
    • Tago, Masao;
    • Nakagawa, Keiichi;
    • Toyoda, Tatsuya;
    • Hatano, Kazuo;
    • Kenjyo, Masahiro;
    • Oya, Natsuo;
    • Hirota, Saeko;
    • Shioura, Hiroki;
    • Kunieda, Etsuo;
    • Hayakawa, Taisuke;
    • Katoh, Norio;
    • Kobashi, Gen;
    • Inomata, Taisuke
    Publication type:
    Article
    28
    29
    30

    Safety, biodistribution, pharmacokinetics, and immunogenicity of <sup>99m</sup>Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.

    Published in:
    Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 576, doi. 10.1007/s00262-003-0396-5
    By:
    • Colnot, David R.;
    • Roos, Jan C.;
    • de Bree, Remco;
    • Wilhelm, Abraham J.;
    • Kummer, J. Alain;
    • Hanft, Gertraud;
    • Heider, Karl-Heinz;
    • Stehle, Gerd;
    • Snow, Gordon B.;
    • van Dongen, Guus A. M. S.
    Publication type:
    Article
    31
    32